{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T14:14:54Z","timestamp":1794492894531,"version":"4.9.1"},"reference-count":30,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T00:00:00Z","timestamp":1714089600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J Lab Hematology"],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>The classic Philadelphia chromosome\u2013negative myeloproliferative neoplasms (Ph (\u2010) MPNs), have variable potential for progression to the blast phase (MPN\u2010BP) of the disease. Except initiated by distinct driver mutations, MPN\u2010BP frequently carry similar genetic abnormalities defining acute myeloid leukemia myelodysplasia\u2010related (AML\u2010MR). Because of dissimilar initial pathogenesis, MPN\u2010BP and AML\u2010MR are retained under different disease categories. To determine if separately classifying these entities is justified, we compare MPN\u2010BP with AML\u2010MR patients based on mutational landscape and clinical parameters.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>104 MPN\u2010BP patients and 145 AML\u2010MR patients were identified with available clinical, cytogenetic, and genetic data.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>AML\u2010MR patients presented with a higher blast count (median, 51% vs. 30%) while MPN\u2010BP patients had higher WBC counts, platelet counts and bone marrow cellularity (all p&lt;0.0001). Patients with MPN\u2010BP showed similar genetic mutations with similar mutation pattern (functional domain, hotspot and locus involved by the mutations) but a different mutation rate from AML\u2010MR, with more frequent <jats:italic>JAK2<\/jats:italic>, <jats:italic>CALR<\/jats:italic>, <jats:italic>MPL, ASXL1<\/jats:italic>, <jats:italic>IDH2<\/jats:italic>, <jats:italic>SETBP1<\/jats:italic> and <jats:italic>SRSF2<\/jats:italic> mutations and less frequent <jats:italic>TP53<\/jats:italic> and <jats:italic>DNMT3A<\/jats:italic> mutations<jats:italic>.<\/jats:italic> The overall survival (OS) of MPN\u2010BP (OS post\u2010BP\u2010progression) is comparable to that of AML\u2010MR (median OS, 9.5 months vs. 13.1 months, p=0.20). In addition, the subgroups of MPN\u2010BP show similar OS as AML\u2010MR. When harboring certain mutation such as <jats:italic>TP53<\/jats:italic>, <jats:italic>ASXL1<\/jats:italic>, <jats:italic>DNMT3A<\/jats:italic>, <jats:italic>TET2<\/jats:italic>, <jats:italic>RUNX1<\/jats:italic>, <jats:italic>IDH1<\/jats:italic>, <jats:italic>IDH2<\/jats:italic>, <jats:italic>EZH2<\/jats:italic>, <jats:italic>U2AF1<\/jats:italic>, <jats:italic>BCOR<\/jats:italic> and <jats:italic>SRSF2<\/jats:italic>, MPN\u2010BP and AML\u2010MR patients carrying the same somatic mutation show no difference in OS.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>MPN\u2010BP and AML\u2010MR harbor similar somatic mutations and clinical outcomes, suggesting a unified clinical disease entity.<\/jats:p><\/jats:sec>","DOI":"10.1111\/ijlh.14280","type":"journal-article","created":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T07:29:18Z","timestamp":1714116558000},"page":"687-694","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A comparative analysis of the clinical and genetic profiles of blast phase\u00a0<i>BCR::ABL1<\/i>\u2010negative myeloproliferative neoplasm and acute myeloid leukemia, myelodysplasia\u2010related"],"prefix":"10.1111","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6661-9410","authenticated-orcid":false,"given":"Dong","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine University of Connecticut  Farmington Connecticut USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Geyer","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Weill Cornell Medical College Cornell University  New York New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Bagg","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine Hospital of the University of Pennsylvania  Philadelphia Pennsylvania USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Hasserjian","sequence":"additional","affiliation":[{"name":"Department of Pathology, Massachusetts General Hospital Harvard Medical School  Boston Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4250-3891","authenticated-orcid":false,"given":"Olga K.","family":"Weinberg","sequence":"additional","affiliation":[{"name":"Department of Pathology University of Texas Southwestern Medical Center  Dallas Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,4,26]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01613-1"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022015850"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-018-0019-y"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-03-785907"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11899-015-0259-0"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2017.181842"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-03-643544"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.13565"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2020.100712"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2008.11.006"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021006239"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2017.230"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-11-537167"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021014472"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1309\/AJCP58RSMFRHLHHH"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022016490"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.205013"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2011.051532"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1186\/1756-8722-5-12"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2012.06.032"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018015875"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-128309"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1005143"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2016.126"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-023-01919-8"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022008282"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.222323"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-12-399337"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/aqad077"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10030436"}],"container-title":["International Journal of Laboratory Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ijlh.14280","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T14:38:24Z","timestamp":1738247904000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ijlh.14280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,26]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["10.1111\/ijlh.14280"],"URL":"https:\/\/doi.org\/10.1111\/ijlh.14280","archive":["Portico"],"relation":{},"ISSN":["1751-5521","1751-553X"],"issn-type":[{"value":"1751-5521","type":"print"},{"value":"1751-553X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,26]]},"assertion":[{"value":"2023-11-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}